Bioblast Pharma

Hope should not be rare

Dalia Megiddo

Dalia Megiddo

Dalia Megiddo, MD, MBA

Bioblast Pharma Board of Directors Member and Co-founder

Dr. Dalia Megiddo is Bioblast Pharma’s co-founder. In February 2008, she co-founded and became a director of Alcobra Ltd., a NASDAQ-traded company primarily focused on the development and commercialization of proprietary drug, MG01CI, to treat attention deficit hyperactivity disorder. Dr. Megiddo is an entrepreneur and a medical doctor in family medicine. Since 2000, she has been a manager of InnoMed Ventures, an Israeli venture capital fund focused on life sciences. From 2006 to 2010, Dr. Megiddo was also a manager of 7 Health Ventures, an Israeli venture capital fund. She is also the founder of a number of life science companies.

Dr. Megiddo received her MD degree from Hebrew University Hadassah Medical School with a specialist degree in Family Medicine. She also holds an MBA from the Kellogg-Recanati School of Business.

Learn about other members of the Board of Directors of Bioblast